Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial.

Stahler A, Karthaus M, Fruehauf S, Graeven U, Müller L, Fischer von Weikersthal L, Caca K, Goekkurt E, Ballhausen A, Sommerhäuser G, Alig AHS, Held S, Jarosch A, Horst D, Reinacher-Schick A, Kasper S, Heinemann V, Stintzing S, Trarbach T, Modest DP

Open source

DOI: 10.1016/j.eclinm.2024.103004
Published: 2025 Jan
Container: EClinicalMedicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2024.103004,
  title = {Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial.},
  author = {Stahler A and Karthaus M and Fruehauf S and Graeven U and Müller L and Fischer von Weikersthal L and Caca K and Goekkurt E and Ballhausen A and Sommerhäuser G and Alig AHS and Held S and Jarosch A and Horst D and Reinacher-Schick A and Kasper S and Heinemann V and Stintzing S and Trarbach T and Modest DP},
  year = {2025},
  journal = {EClinicalMedicine},
  doi = {10.1016/j.eclinm.2024.103004},
  url = {https://doi.org/10.1016/j.eclinm.2024.103004}
}

RIS

TY  - JOUR
TI  - Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial.
AU  - Stahler A
AU  - Karthaus M
AU  - Fruehauf S
AU  - Graeven U
AU  - Müller L
AU  - Fischer von Weikersthal L
AU  - Caca K
AU  - Goekkurt E
AU  - Ballhausen A
AU  - Sommerhäuser G
AU  - Alig AHS
AU  - Held S
AU  - Jarosch A
AU  - Horst D
AU  - Reinacher-Schick A
AU  - Kasper S
AU  - Heinemann V
AU  - Stintzing S
AU  - Trarbach T
AU  - Modest DP
PY  - 2025
JO  - EClinicalMedicine
DO  - 10.1016/j.eclinm.2024.103004
UR  - https://doi.org/10.1016/j.eclinm.2024.103004
ER  -

APA

A, S., M, K., S, F., U, G., L, M., L, F. V. W., K, C., E, G., A, B., G, S., AHS, A., S, H., A, J., D, H., A, R., S, K., V, H., S, S., T, T., & DP, M. (2025). Panitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial.. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2024.103004

Source records

pubmed · retrieved 2026-09-26T08:36:28.507Z